This activity is part of the Frankly Speaking with Dr. Frank Domino podcast series.
Frankly Speaking CME 248

Podcast

Aspirin—Not Really for Primary Prevention - Frankly Speaking EP 248Guest: Jill M. Terrien, PhD, ANP-BC
Music Credit: Richard Onorato

Join us to hear a discussion on the important changes the AHA/ACC and USPSTF have made to their positions on the use of aspirin for primary prevention of cardiovascular disease. The organizations note that while aspirin for primary prevention lowers the risk of a myocardial infarction, its harmful effects may outweigh its benefits. Learn the aspirin recommendations for your patients in their 40s, 50s, and 60s who are at higher risk for a cardiovascular event.

Episode Resources and Links: 

Begin

Already listened on another platform?

Claim Credits

CME/CE Information

0 Credits - Not for CME/CE Credit

Release Date: 11/1/2021

Expiration Date: 11/1/2022

Learning Objectives

  • Review the rationale for aspirin’s role in cardiovascular risk prevention
  • Summarize new data discussing risks and benefits of aspirin for primary prevention
     

     

 

Faculty

Frank J. Domino, MD

Professor, Family Medicine and Community Health,
University of Massachusetts Medical School, Worcester, MA

Learn More

Jill M. Terrien, PhD, ANP-BC

Associate Professor, Director NP Programs
UMMS-GSN 

Learn More

Supporters and Partners

Commercial Supporter

Not Applicable

Education Partner

Not Applicable

Aspirin—Not Really for Primary Prevention - Frankly Speaking EP 248

Begin